What is the global market size of Nicotine Gum Market?

Nicotine Gum Market size was valued at USD 1.49 billion in 2021 and is poised to grow from USD 1.56 billion in 2022 to USD 2.17 billion by 2030, growing at a CAGR of 4.8% in the forecast period (2023-2030).

Nicotine Gum Market Size, Share, Growth Analysis, By Type(2 mg nicotine gum, 4 mg nicotine gum), By Distribution channel (Supermarkets, hypermarkets) - Industry Forecast 2024-2031

Q: Who are the key vendors in the Global Nicotine Gum Market?

Global nicotine gum market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'GlaxoSmithKline', 'Johnson & Johnson', 'Perrigo Company plc', 'Pfizer Inc.', 'Novartis AG', 'Revolymer PLC', 'Cambrex Corporation', 'Fertin Pharma A/S', 'Alchem International Ltd.', 'Dr. Reddy's Laboratories Ltd.', 'ConfiDent AB', 'MCNEIL-PPC, Inc.', 'Tendex Holdings Limited', 'Parnell Pharmaceuticals Inc.', 'Takeda Pharmaceutical Company Limited', 'LEO Pharma A/S', 'Sun Pharmaceutical Industries Ltd.', 'Perrigo UK FINCO Limited', 'Pharmacia Corporation', 'Procter & Gamble Co.'

Report ID: SQSG35I2048 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 64 | Figures: 75

Nicotine Gum Market Dynamics

Nicotine Gum Market Driver

The rising prevalence of diseases such as lung cancer, heart disease, and respiratory problems is driving the market. In reality, it is caused by rising tobacco use in unique ways that endangers global public safety. Such factor could propel the nicotine gum market forward.

Nicotine Gum Market Restraint

Some common adverse reactions of nicotine gum include high blood pressure, rapid heart rate, dizziness, insomnia, irritability, loss of appetite, indigestion, heartburn, vomiting, and hiccups. Furthermore, if it is chewed frequently and for an extended period of time, it causes nausea and abdominal distress. As a result, such factor is predicted to suppress market growth during the forecast period.

Nicotine Gum Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nicotine Gum Market size was valued at USD 1.49 billion in 2019 and is poised to grow from USD 1.56 billion in 2023 to USD 2.17 billion by 2031, growing at a CAGR of 4.8% in the forecast period (2024-2031).

nicotine gum market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'GlaxoSmithKline', 'Johnson & Johnson', 'Perrigo Company plc', 'Pfizer Inc.', 'Novartis AG', 'Revolymer PLC', 'Cambrex Corporation', 'Fertin Pharma A/S', 'Alchem International Ltd.', 'Dr. Reddy's Laboratories Ltd.', 'ConfiDent AB', 'MCNEIL-PPC, Inc.', 'Tendex Holdings Limited', 'Parnell Pharmaceuticals Inc.', 'Takeda Pharmaceutical Company Limited', 'LEO Pharma A/S', 'Sun Pharmaceutical Industries Ltd.', 'Perrigo UK FINCO Limited', 'Pharmacia Corporation', 'Procter & Gamble Co.'

The rising prevalence of diseases such as lung cancer, heart disease, and respiratory problems is driving the market. In reality, it is caused by rising tobacco use in unique ways that endangers public safety. Such factor could propel the nicotine gum market forward.

In the coming years, the market will benefit from increased health consciousness and a transition toward a healthier lifestyle. The government's emphasis on lowering smoking rates has increased significantly. Governments in all regions support broad approaches to tobacco control, along with a variety of actions such as a ban on tobacco promotion and advertising. It includes gradually increasing tobacco taxes in conjunction with measures to combat smuggling, which may limit smoking in the working place and public places.

North America has seen an increase in the percentage of health-conscious consumers, which has been bolstered by campaigns and government initiatives, propelling regional market growth. Furthermore, the region is home to significant brands that are focusing on product innovation in order to capitalise on rising demand and gain a competitive edge in the market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Nicotine Gum Market Size, Share, Growth Analysis, By Type(2 mg nicotine gum, 4 mg nicotine gum), By Distribution channel (Supermarkets, hypermarkets) - Industry Forecast 2024-2031

Nicotine Gum Market Dynamics

Nicotine Gum Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Nicotine Gum Market?

Who are the key vendors in the Nicotine Gum Market?

What is the key driver of Nicotine Gum Market?

What is the key market trend for Nicotine Gum Market?

Which region accounted for the largest share in Nicotine Gum Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300